Literature DB >> 32070856

Neuromodulated attention and goal-driven perception in uncertain domains.

Xinyun Zou1, Soheil Kolouri2, Praveen K Pilly3, Jeffrey L Krichmar4.   

Abstract

In uncertain domains, the goals are often unknown and need to be predicted by the organism or system. In this paper, contrastive Excitation Backprop (c-EB) was used in two goal-driven perception tasks - one with pairs of noisy MNIST digits and the other with a robot in an action-based attention scenario. The first task included attending to even, odd, low, and high digits, whereas the second task included action goals, such as "eat", "work-on-computer", "read", and "say-hi" that led to attention to objects associated with those actions. The system needed to increase attention to target items and decrease attention to distractor items and background noise. Because the valid goal was unknown, an online learning model based on the cholinergic and noradrenergic neuromodulatory systems was used to predict a noisy goal (expected uncertainty) and re-adapt when the goal changed (unexpected uncertainty). This neurobiologically plausible model demonstrates how neuromodulatory systems can predict goals in uncertain domains and how attentional mechanisms can enhance the perception for that goal.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Keywords:  Contrastive excitation backprop; Goal-driven perception; Neuromodulation; Top-down attention; Uncertainty

Year:  2020        PMID: 32070856     DOI: 10.1016/j.neunet.2020.01.031

Source DB:  PubMed          Journal:  Neural Netw        ISSN: 0893-6080


  2 in total

1.  Design Principles for Neurorobotics.

Authors:  Jeffrey L Krichmar; Tiffany J Hwu
Journal:  Front Neurorobot       Date:  2022-05-25       Impact factor: 3.493

Review 2.  Neurorobots as a Means Toward Neuroethology and Explainable AI.

Authors:  Kexin Chen; Tiffany Hwu; Hirak J Kashyap; Jeffrey L Krichmar; Kenneth Stewart; Jinwei Xing; Xinyun Zou
Journal:  Front Neurorobot       Date:  2020-10-19       Impact factor: 2.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.